These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27466763)

  • 1. Ligand Efficiency Indices (LEIs): More than a Simple Efficiency Yardstick.
    Abad-Zapatero C; Blasi D
    Mol Inform; 2011 Mar; 30(2-3):122-32. PubMed ID: 27466763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery Strategies.
    Blasi D; Arsequell G; Valencia G; Nieto J; Planas A; Pinto M; Centeno NB; Abad-Zapatero C; Quintana J
    Mol Inform; 2011 Mar; 30(2-3):161-7. PubMed ID: 27466770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation.
    Abad-Zapatero C; Perišić O; Wass J; Bento AP; Overington J; Al-Lazikani B; Johnson ME
    Drug Discov Today; 2010 Oct; 15(19-20):804-11. PubMed ID: 20727982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand efficiency indices for effective drug discovery: a unifying vector formulation.
    Abad-Zapatero C
    Expert Opin Drug Discov; 2021 Jul; 16(7):763-775. PubMed ID: 33522838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AtlasCBS: a web server to map and explore chemico-biological space.
    Cortés-Cabrera A; Morreale A; Gago F; Abad-Zapatero C
    J Comput Aided Mol Des; 2012 Sep; 26(9):995-1003. PubMed ID: 22798082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative variables in drug discovery: promises and challenges.
    Abad-Zapatero C; Champness EJ; Segall MD
    Future Med Chem; 2014 Apr; 6(5):577-93. PubMed ID: 24649959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand efficiency indices for effective drug discovery.
    Abad-Zapatero C
    Expert Opin Drug Discov; 2007 Apr; 2(4):469-88. PubMed ID: 23484756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
    Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N
    J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conciliating binding efficiency and polypharmacology.
    Mestres J; Gregori-Puigjané E
    Trends Pharmacol Sci; 2009 Sep; 30(9):470-4. PubMed ID: 19717193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training based on ligand efficiency improves prediction of bioactivities of ligands and drug target proteins in a machine learning approach.
    Sugaya N
    J Chem Inf Model; 2013 Oct; 53(10):2525-37. PubMed ID: 24020509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computational fragment-based de novo design protocol guided by ligand efficiency indices (LEI).
    Cortés-Cabrera Á; Gago F; Morreale A
    Methods Mol Biol; 2015; 1289():89-100. PubMed ID: 25709035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-receptor interaction platforms and their applications for drug discovery.
    Fang Y
    Expert Opin Drug Discov; 2012 Oct; 7(10):969-88. PubMed ID: 22860803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand efficiency-based support vector regression models for predicting bioactivities of ligands to drug target proteins.
    Sugaya N
    J Chem Inf Model; 2014 Oct; 54(10):2751-63. PubMed ID: 25220713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand efficiency and fragment-based drug discovery.
    Bembenek SD; Tounge BA; Reynolds CH
    Drug Discov Today; 2009 Mar; 14(5-6):278-83. PubMed ID: 19073276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding efficiency: trends, physical basis, and implications.
    Reynolds CH; Tounge BA; Bembenek SD
    J Med Chem; 2008 Apr; 51(8):2432-8. PubMed ID: 18380424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase.
    García-Sosa AT; Sild S; Takkis K; Maran U
    J Chem Inf Model; 2011 Oct; 51(10):2595-611. PubMed ID: 21875140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.
    Murray CW; Carr MG; Callaghan O; Chessari G; Congreve M; Cowan S; Coyle JE; Downham R; Figueroa E; Frederickson M; Graham B; McMenamin R; O'Brien MA; Patel S; Phillips TR; Williams G; Woodhead AJ; Woolford AJ
    J Med Chem; 2010 Aug; 53(16):5942-55. PubMed ID: 20718493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.